Targeted lung cancer drug wows meetingPromising early trial results for crizotinib highlighted in plenary session Many NPs lack oncology expertise: studySupervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Sponge-derived drug extends breast cancer survival Radiation-hormone therapy combo best for high-risk prostate cancer Targeted therapy battles late-stage lung cancer Researchers tailor treatment to tumour’s molecular signature Breast density decrease linked with lower cancer risk Tamoxifen vs. raloxifene: Which is best for breast cancer prevention? Followup study further delineates the differences in effectiveness and toxicity between the two selective estrogen receptor modulators First Previous 63 64 65 66 67 Next Last
